• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dynamics of SLC25A51 reveal preference for oxidized NAD and substrate led transport.SLC25A51 的动力学特性揭示了其对氧化型 NAD 和底物促进转运的偏好。
EMBO Rep. 2023 Oct 9;24(10):e56596. doi: 10.15252/embr.202256596. Epub 2023 Aug 14.
2
Layered mechanisms regulating the human mitochondrial NAD+ transporter SLC25A51.调控人线粒体 NAD+转运蛋白 SLC25A51 的层状机制。
Biochem Soc Trans. 2023 Dec 20;51(6):1989-2004. doi: 10.1042/BST20220318.
3
SLC25A51 is a mammalian mitochondrial NAD transporter.SLC25A51 是一种哺乳动物线粒体 NAD 转运蛋白。
Nature. 2020 Dec;588(7836):174-179. doi: 10.1038/s41586-020-2741-7. Epub 2020 Sep 9.
4
MCART1/SLC25A51 is required for mitochondrial NAD transport.线粒体NAD转运需要MCART1/SLC25A51。
Sci Adv. 2020 Oct 21;6(43). doi: 10.1126/sciadv.abe5310. Print 2020 Oct.
5
The mitochondrial NAD transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions.线粒体 NAD 转运蛋白 SLC25A51 是一种饥饿诱导基因,影响 SIRT3 功能。
Metabolism. 2022 Oct;135:155275. doi: 10.1016/j.metabol.2022.155275. Epub 2022 Aug 4.
6
SLC25A51 decouples the mitochondrial NAD/NADH ratio to control proliferation of AML cells.SLC25A51 使线粒体 NAD/NADH 比率解偶联,以控制 AML 细胞的增殖。
Cell Metab. 2024 Apr 2;36(4):808-821.e6. doi: 10.1016/j.cmet.2024.01.013. Epub 2024 Feb 14.
7
Welcome to the Family: Identification of the NAD Transporter of Animal Mitochondria as Member of the Solute Carrier Family SLC25.欢迎加入家族:鉴定动物线粒体 NAD 转运蛋白为溶质载体家族 SLC25 的成员。
Biomolecules. 2021 Jun 14;11(6):880. doi: 10.3390/biom11060880.
8
Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import.SLC25A51 作为人类线粒体 NAD 摄取的调节剂的上位驱动鉴定。
Nat Commun. 2020 Dec 1;11(1):6145. doi: 10.1038/s41467-020-19871-x.
9
Evidence for Non-Essential Salt Bridges in the M-Gates of Mitochondrial Carrier Proteins.线粒体载体蛋白 M 门中非必需盐桥的证据。
Int J Mol Sci. 2022 May 2;23(9):5060. doi: 10.3390/ijms23095060.
10
Cardiolipin dynamics and binding to conserved residues in the mitochondrial ADP/ATP carrier.心磷脂动力学及其与线粒体 ADP/ATP 载体保守残基的结合。
Biochim Biophys Acta Biomembr. 2018 May;1860(5):1035-1045. doi: 10.1016/j.bbamem.2018.01.017. Epub 2018 Jan 31.

引用本文的文献

1
GEMCAT-a new algorithm for gene expression-based prediction of metabolic alterations.GEMCAT——一种基于基因表达预测代谢改变的新算法。
NAR Genom Bioinform. 2025 Jan 31;7(1):lqaf003. doi: 10.1093/nargab/lqaf003. eCollection 2025 Mar.
2
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells.衰老与神经退行性变的病理生物化学:脑细胞中NAD+代谢的失调
Biomolecules. 2024 Dec 6;14(12):1556. doi: 10.3390/biom14121556.
3
Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency.在柠檬酸缺乏症中,3-磷酸甘油激活碳水化合物反应元件结合蛋白(ChREBP)、成纤维细胞生长因子21(FGF21)转录及脂肪生成。
bioRxiv. 2024 Dec 27:2024.12.27.630525. doi: 10.1101/2024.12.27.630525.
4
Functional diversity among cardiolipin binding sites on the mitochondrial ADP/ATP carrier.线粒体 ADP/ATP 载体上的 cardiolipin 结合位点的功能多样性。
EMBO J. 2024 Jul;43(14):2979-3008. doi: 10.1038/s44318-024-00132-2. Epub 2024 Jun 5.
5
SLC25A51 decouples the mitochondrial NAD/NADH ratio to control proliferation of AML cells.SLC25A51 使线粒体 NAD/NADH 比率解偶联,以控制 AML 细胞的增殖。
Cell Metab. 2024 Apr 2;36(4):808-821.e6. doi: 10.1016/j.cmet.2024.01.013. Epub 2024 Feb 14.
6
Layered mechanisms regulating the human mitochondrial NAD+ transporter SLC25A51.调控人线粒体 NAD+转运蛋白 SLC25A51 的层状机制。
Biochem Soc Trans. 2023 Dec 20;51(6):1989-2004. doi: 10.1042/BST20220318.
7
Conserved cardiolipin-mitochondrial ADP/ATP carrier interactions assume distinct structural and functional roles that are clinically relevant.保守的心磷脂 - 线粒体ADP/ATP载体相互作用具有不同的结构和功能作用,这些作用与临床相关。
bioRxiv. 2023 May 6:2023.05.05.539595. doi: 10.1101/2023.05.05.539595.

本文引用的文献

1
Structural basis for the binding of DNP and purine nucleotides onto UCP1.UCP1 与 DNP 和嘌呤核苷酸结合的结构基础。
Nature. 2023 Aug;620(7972):226-231. doi: 10.1038/s41586-023-06332-w. Epub 2023 Jun 19.
2
Human mitochondrial ADP/ATP carrier SLC25A4 operates with a ping-pong kinetic mechanism.人线粒体 ADP/ATP 载体 SLC25A4 采用乒乓机制运作。
EMBO Rep. 2023 Aug 3;24(8):e57127. doi: 10.15252/embr.202357127. Epub 2023 Jun 6.
3
Structural basis of purine nucleotide inhibition of human uncoupling protein 1.嘌呤核苷酸抑制人解偶联蛋白 1 的结构基础。
Sci Adv. 2023 Jun 2;9(22):eadh4251. doi: 10.1126/sciadv.adh4251. Epub 2023 May 31.
4
Improved Yield for the Enzymatic Synthesis of Radiolabeled Nicotinamide Adenine Dinucleotide.放射性标记烟酰胺腺嘌呤二核苷酸酶促合成的产率提高
ACS Bio Med Chem Au. 2023 Jan 5;3(1):46-50. doi: 10.1021/acsbiomedchemau.2c00065. eCollection 2023 Feb 15.
5
Substrate binding in the mitochondrial ADP/ATP carrier is a step-wise process guiding the structural changes in the transport cycle.基质结合在线粒体 ADP/ATP 载体中是一个逐步的过程,指导着运输循环中的结构变化。
Nat Commun. 2022 Jun 23;13(1):3585. doi: 10.1038/s41467-022-31366-5.
6
The effects of cardiolipin on the structural dynamics of the mitochondrial ADP/ATP carrier in its cytosol-open state.心磷脂对胞质开放状态下线粒体 ADP/ATP 载体结构动力学的影响。
J Lipid Res. 2022 Jun;63(6):100227. doi: 10.1016/j.jlr.2022.100227. Epub 2022 May 12.
7
Evidence for Non-Essential Salt Bridges in the M-Gates of Mitochondrial Carrier Proteins.线粒体载体蛋白 M 门中非必需盐桥的证据。
Int J Mol Sci. 2022 May 2;23(9):5060. doi: 10.3390/ijms23095060.
8
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
9
Welcome to the Family: Identification of the NAD Transporter of Animal Mitochondria as Member of the Solute Carrier Family SLC25.欢迎加入家族:鉴定动物线粒体 NAD 转运蛋白为溶质载体家族 SLC25 的成员。
Biomolecules. 2021 Jun 14;11(6):880. doi: 10.3390/biom11060880.
10
Structural Mechanism of Transport of Mitochondrial Carriers.线粒体载体运输的结构机制。
Annu Rev Biochem. 2021 Jun 20;90:535-558. doi: 10.1146/annurev-biochem-072820-020508. Epub 2021 Feb 8.

SLC25A51 的动力学特性揭示了其对氧化型 NAD 和底物促进转运的偏好。

Dynamics of SLC25A51 reveal preference for oxidized NAD and substrate led transport.

机构信息

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.

Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA.

出版信息

EMBO Rep. 2023 Oct 9;24(10):e56596. doi: 10.15252/embr.202256596. Epub 2023 Aug 14.

DOI:10.15252/embr.202256596
PMID:37575034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10561365/
Abstract

SLC25A51 is a member of the mitochondrial carrier family (MCF) but lacks key residues that contribute to the mechanism of other nucleotide MCF transporters. Thus, how SLC25A51 transports NAD across the inner mitochondrial membrane remains unclear. To elucidate its mechanism, we use Molecular Dynamics simulations to reconstitute SLC25A51 homology models into lipid bilayers and to generate hypotheses to test. We observe spontaneous binding of cardiolipin phospholipids to three distinct sites on the exterior of SLC25A51's central pore and find that mutation of these sites impairs cardiolipin binding and transporter activity. We also observe that stable formation of the required matrix gate is controlled by a single salt bridge. We identify binding sites in SLC25A51 for NAD and show that its selectivity for NAD is guided by an electrostatic interaction between the charged nicotinamide ring in the ligand and a negatively charged patch in the pore. In turn, interaction of NAD with interior residue E132 guides the ligand to dynamically engage and weaken the salt bridge gate, representing a ligand-induced initiation of transport.

摘要

SLC25A51 是线粒体载体家族 (MCF) 的成员,但缺乏有助于其他核苷酸 MCF 转运蛋白机制的关键残基。因此,SLC25A51 如何将 NAD 转运穿过线粒体内膜仍不清楚。为了阐明其机制,我们使用分子动力学模拟将 SLC25A51 同源模型重建到脂质双层中,并生成假设进行测试。我们观察到心磷脂磷脂自发结合到 SLC25A51 中心孔外部的三个不同位点,并发现这些位点的突变会损害心磷脂结合和转运体活性。我们还观察到所需基质门的稳定形成受单一盐桥控制。我们确定了 SLC25A51 中 NAD 的结合位点,并表明其对 NAD 的选择性受配体中带电荷的烟酰胺环与孔中带负电荷的斑块之间的静电相互作用的指导。反过来,NAD 与内部残基 E132 的相互作用引导配体动态参与并削弱盐桥门,代表配体诱导的转运起始。